| Literature DB >> 31354511 |
Juan Antonio Martos-Sitcha1, Paula Simó-Mirabet1, Verónica de Las Heras1, Josep Àlvar Calduch-Giner1, Jaume Pérez-Sánchez1.
Abstract
Two different O2 levels (normoxia: 75-85% O2 saturation; moderate hypoxia: 42-43% O2 saturation) and stocking densities (LD: 9.5, and HD: 19 kg/m3) were assessed on gilthead sea bream (Sparus aurata) in a 3-week feeding trial. Reduced O2 availability had a negative impact on feed intake and growth rates, which was exacerbated by HD despite of the improvement in feed efficiency. Blood physiological hallmarks disclosed the enhancement in O2-carrying capacity in fish maintained under moderate hypoxia. This feature was related to a hypo-metabolic state to cope with a chronic and widespread environmental O2 reduction, which was accompanied by a differential regulation of circulating cortisol and growth hormone levels. Customized PCR-arrays were used for the simultaneous gene expression profiling of 34-44 selected stress and metabolic markers in liver, white skeletal muscle, heart, and blood cells. The number of differentially expressed genes ranged between 22 and 19 in liver, heart, and white skeletal muscle to 5 in total blood cells. Partial Least-Squares Discriminant Analysis (PLS-DA) explained [R2Y(cum)] and predicted [Q2Y(cum)] up to 95 and 65% of total variance, respectively. The first component (R2Y = 0.2889) gathered fish on the basis of O2 availability, and liver and cardiac genes on the category of energy sensing and oxidative metabolism (cs, hif-1α, pgc1α, pgc1β, sirts 1-2-4-5-6-7), antioxidant defense and tissue repair (prdx5, sod2, mortalin, gpx4, gr, grp-170, and prdx3) and oxidative phosphorylation (nd2, nd5, and coxi) highly contributed to this separation. The second component (R2Y = 0.2927) differentiated normoxic fish at different stocking densities, and the white muscle clearly promoted this separation by a high over-representation of genes related to GH/IGF system (ghr-i, igfbp6b, igfbp5b, insr, igfbp3, and igf-i). The third component (R2Y = 0.2542) discriminated the effect of stocking density in fish exposed to moderate hypoxia by means of hepatic fatty acid desaturases (fads2, scd1a, and scd1b) and muscle markers of fatty acid oxidation (cpt1a). All these findings disclose the different contribution of analyzed tissues (liver ≥ heart > muscle > blood) and specific genes to the hypoxic- and crowding stress-mediated responses. This study will contribute to better explain and understand the different stress resilience of farmed fish across individuals and species.Entities:
Keywords: Sparus aurata; hematology; hypometabolism; hypoxia; limiting oxygen saturation; stocking density; tissue-specific transcriptomics
Year: 2019 PMID: 31354511 PMCID: PMC6635561 DOI: 10.3389/fphys.2019.00840
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Genes included in the liver (L), white muscle (M), heart (H), and total blood cells (B) pathway-focused PCR arrays.
| Gene name/category | Symbol | Gene name/category | Symbol |
|---|---|---|---|
| Growth hormone receptor I | Elongation of very long chain fatty acids 1 | ||
| Growth hormone receptor II | Elongation of very long chain fatty acids 4 | ||
| Insulin-like growth factor-I | Elongation of very long chain fatty acids 5 | ||
| Insulin-like growth factor-II | Elongation of very long chain fatty acids 6 | ||
| Insulin-like growth factor binding protein 1a | Fatty acid desaturase 2 | ||
| Insulin-like growth factor binding protein 2b | Stearoyl-CoA desaturase 1a | ||
| Insulin-like growth factor binding protein 3 | Stearoyl-CoA desaturase 1b | ||
| Insulin-like growth factor binding protein 4 | Lipoprotein lipase | ||
| Insulin-like growth factor binding protein 5b | Peroxisome proliferator-activated receptor α | ||
| Insulin-like growth factor binding protein 6b | Peroxisomeproliferator-activated receptor γ | ||
| Insulin receptor | |||
| Insulin-like growth factor receptor I | |||
| Insulin-like growth factor receptor II | Catalase | ||
| Glutathione peroxidase 4 | |||
| Glutathione reductase | |||
| Sirtuin 1 | Peroxiredoxin 3 | ||
| Sirtuin 2 | Peroxiredoxin 5 | ||
| Sirtuin 3 | Superoxide dismutase [Mn] | ||
| Sirtuin 4 | Glucose-regulated protein, 170 kDa | ||
| Sirtuin 5 | Glucose-regulated protein, 94 kDa | ||
| Sirtuin 6 | 70 kDa heat shock protein, mitochondrial | ||
| Sirtuin 7 | Glutathione S-transferase 3 | ||
| Carnitine palmitoyltransferase 1A | |||
| Citrate synthase | |||
| Proliferator-activated receptor gamma coactivator 1 alpha | Myoblast determination protein 1 | ||
| Proliferator-activated receptor gamma coactivator 1 beta | Myogenic factor MYOD2 | ||
| Hypoxia inducible factor-1 alpha | Myogenic factor 5 | ||
| Myogenic factor 6 | |||
| Myostatin/Growth differentiation factor 8 | |||
| Uncoupling protein 1 | Myocyte-specific enhancer factor 2A | ||
| Uncoupling protein 2 | Myocyte-specific enhancer factor 2C | ||
| Uncoupling protein 3 | Follistatin | ||
| Aryl hydrocarbon receptor 1 | Glucocorticoid receptor | ||
| Cytochrome P450 1A1 | Estrogen receptor alpha | ||
| Nuclear respiratory factor 1 | |||
| Mitochondrial import receptor subunit Tom70 | |||
| Mitochondrial import receptor subunit Tom34 | Mitofusin 2 | ||
| Mitochondrial import receptor subunit Tom22 | Mitochondrial fission factor homolog B | ||
| Mitochondrial import inner membrane translocase subunit 44 | Mitochondrial Rho GTPase 1 | ||
| Mitochondrial import inner membrane translocase subunit 23 | Mitochondrial Rho GTPase 2 | ||
| Mitochondrial import inner membrane translocase subunit Tim8A | Apoptosis-related protein 1 | ||
| Mitochondrial import inner membrane translocase subunit Tim10 | |||
| Mitochondrial import inner membrane translocase subunit Tim9 | |||
| Cytochrome c oxidase subunit I | |||
| Cytochrome c oxidase subunit II | |||
| Cytochrome c oxidase subunit III | |||
| NADH-ubiquinone oxidoreductase chain 2 | Cytochrome c oxidase subunit 4 isoform 1 | ||
| NADH-ubiquinone oxidoreductase chain 5 | Cytochrome c oxidase subunit 5A, mitochondrial-like isoform 2 | ||
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | Cytochrome c oxidase subunit 6A isoform 2 | ||
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 | Cytochrome c oxidase subunit 6C1 | ||
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 | Cytochrome c oxidase subunit 7B | ||
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 | Cytochrome c oxidase subunit 8B | ||
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5 | SCO1 protein homolog, mitochondrial | ||
| NADH dehydrogenase iron-sulfur protein 2 | Surfeit locus protein 1 | ||
| NADH dehydrogenase iron-sulfur protein 7 | Cytochrome c oxidase assembly protein COX15 homolog | ||
| NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2 | |||
Effects of rearing density and dissolved oxygen level on gilthead sea bream growth performance on a 21-days feeding trial.
| LD | HD | ||||||
|---|---|---|---|---|---|---|---|
| Normoxia | Hypoxia | Normoxia | Hypoxia | [O2] | Density | Interaction | |
| Initial body weight (g) | 34.54 ± 1.11 | 34.22 ± 0.27 | 34.32 ± 0.34 | 33.25 ± 0.45 | n.s. | n.s. | n.s. |
| Final body weight (g) | 56.04 ± 1.89 | 51.65 ± 0.71 | 54.02 ± 0.50 | 48.54 ± 1.05** | 0.003 | n.s. | n.s. |
| Feed intake (g DM/fish) | 23.78 ± 1.63 | 18.52 ± 0.7* | 24.57 ± 1.06 | 17.54 ± 0.47** | < 0.001 | n.s. | n.s. |
| Weight gain (%)1 | 62.21 ± 0.31 | 50.94 ± 1.34** | 57.43 ± 1.42 | 45.97 ± 1.31** | < 0.001 | 0.003 | n.s. |
| SGR (%)2 | 2.30 ± 0.01 | 1.96 ± 0.04** | 2.16 ± 0.04 | 1.80 ± 0.04** | < 0.001 | 0.004 | n.s. |
| FE (%)3 | 0.91 ± 0.03 | 0.94 ± 0.02 | 0.80 ± 0.02 | 0.87 ± 0.01* | 0.039 | 0.003 | n.s. |
| Liver weight (g) | 0.94 ± 0.07 | 0.67 ± 0.03** | 0.90 ± 0.06 | 0.63 ± 0.03*** | < 0.001 | n.s. | n.s. |
| Viscera weight (g) | 4.41 ± 0.28 | 3.84 ± 0.18 | 4.42 ± 0.19 | 3.68 ± 0.10** | 0.002 | n.s. | n.s. |
| HSI (%)4 | 1.64 ± 0.07 | 1.33 ± 0.06** | 1.58 ± 0.07 | 1.25 ± 0.06** | < 0.001 | n.s. | n.s. |
| VSI (%)5 | 7.78 ± 0.29 | 7.65 ± 0.25 | 7.87 ± 0.24 | 7.38 ± 0.22 | n.s. | n.s. | n.s. |
Effects of rearing density and dissolved oxygen level on blood hematology and plasma levels of metabolites, hormones, and total antioxidant capacity.
| LD | HD | ||||||
|---|---|---|---|---|---|---|---|
| Normoxia | Hypoxia | Normoxia | Hypoxia | [O2] | Density | Interaction | |
| Hemoglobin (g/dl) | 7.18 ± 0.24 | 7.73 ± 0.21 | 7.38 ± 0.14 | 7.77 ± 0.26 | 0.041 | n.s. | n.s. |
| Haematocrit (%) | 22.18 ± 1.10 | 32.91 ± 1.65*** | 28.27 ± 1.77 | 29.90 ± 1.39 | < 0.001 | n.s. | 0.004 |
| RBC× 10-6 (cells/μl)1 | 2.45 ± 0.07 | 2.74 ± 0.07** | 2.38 ± 0.06 | 2.82 ± 0.08*** | < 0.001 | n.s. | n.s. |
| MCHC (pg/10 μm3)2 | 34.07 ± 1.12 | 24.00 ± 1.18*** | 26.62 ± 1.73 | 26.46 ± 1.10 | < 0.001 | n.s. | < 0.001 |
| MCH (pg/cell)3 | 89.79 ± 4.21 | 116.6 ± 4.46** | 116.5 ± 8.28 | 109.5 ± 7.21 | n.s. | n.s. | 0.010 |
| MCV (μm3)4 | 29.50 ± 1.02 | 28.33 ± 0.76 | 31.36 ± 0.93 | 27.73 ± 0.96* | 0.014 | n.s. | n.s. |
| Glucose (mg/dl) | 54.39 ± 1.58 | 52.17 ± 2.44 | 58.04 ± 1.78 | 52.73 ± 2.79 | n.s. | n.s. | n.s. |
| Lactate (mg/dl) | 16.30 ± 2.78 | 4.81 ± 1.41** | 10.22 ± 3.06 | 4.99 ± 0.84 | 0.001 | n.s. | n.s. |
| TAA (mM Trolox)5 | 1.34 ± 0.04 | 1.45 ± 0.04 | 1.48 ± 0.03 | 1.43 ± 0.03 | n.s. | n.s. | 0.026 |
| Cortisol (ng/ml) | 23.40 ± 5.67 | 21.08 ± 5.32 | 35.69 ± 11.15 | 79.25 ± 9.05** | 0.036 | < 0.001 | 0.027 |
| Growth hormone (ng/ml) | 2.34 ± 0.83 | 6.71 ± 1.17* | 5.39 ± 1.29 | 8.33 ± 4.20 | n.s. | n.s. | n.s. |
| Insulin-like growth factor-I (ng/ml) | 46.06 ± 4.76 | 46.59 ± 4.77 | 45.78 ± 2.27 | 41.03 ± 6.29 | n.s. | n.s. | n.s. |
FIGURE 1(A) Graphical representation of the goodness-of-fit of the PLS-DA model. (B) Two-dimensional PLS-DA score plot representing the distribution of the samples between the first two components in the model. (C) Two-dimensional PLS-DA score plot representing the distribution of the samples between the first and third components in the model. R2(cum), explained variance; Q2(cum), predicted variance; LDN, low density normoxia; LDH, low density hypoxia; HDN, high density normoxia; HDH, high density hypoxia.
FIGURE 2(A) Graphical representation of the variable importance (VIP) scores after component 1. (B) Ranking list of genes showing VIP score values above 1.1 and their relative gene expression. Liv, liver; WM, white muscle. Values on relative expression are the mean ± SEM of eight fish (2–3 fish per replicate tank). P-values are the result of two-way analysis of variance. Asterisks in each row indicate significant differences with oxygen level for a given rearing density (SNK test, P < 0.05).
FIGURE 3(A) Graphical representation of the variable importance (VIP) scores after component 2. (B) Ranking list of genes showing VIP score values above 1.1 and their relative gene expression. Cells shaded in blue highlight genes detected as VIP after component 1; cells shaded in yellow highlight genes detected as VIP after component 2. For further details, see legend on Figure 2.
FIGURE 4(A) Graphical representation of the variable importance (VIP) scores after component 3. (B) Ranking list of genes showing VIP score values above 1.1 and their relative gene expression. Cells shaded in blue highlight genes detected as VIP after component 1; cells shaded in yellow highlight genes detected as VIP after component 2; and cells shaded in purple highlight genes detected as VIP after component 3. For further details, see legend on Figure 2.